Bernd Raffeiner

Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

Jeffrey A. Sparks, Zachary S. Wallace, Andrea M. Seet et al. · Annals of the Rheumatic Diseases · 2021 · 241 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry

Saskia Lawson‐Tovey, Anja Strangfeld, Laure Gossec et al. · UCL Discovery (University College London) · 2021 · 172 citations

Medicine, Immunology, Infectious Diseases +17

Cost-effectiveness of etanercept treatment in early active rheumatoid arthritis followed by dose adjustment

Gisela Kobelt, Ingrid Lekander, A Lang et al. · International Journal of Technology Assessment in Health Care · 2011 · 35 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Intravascular large B-cell lymphoma associated with silicone breast implant, HLA-DRB1*11:01, and HLA-DQB1*03:01 manifesting as macrophage activation syndrome and with severe neurological symptoms: a case report

Oswald Moling, Andrea Piccin, Martina Tauber et al. · Journal of Medical Case Reports · 2016 · 35 citations · Full text

Veterinary Medicine, Immunology, Oncology +11

Is ankle involvement underestimated in rheumatoid arthritis? Results of a multicenter ultrasound study

Marwin Gutiérrez, Carlos Pineda, Fausto Salaffi et al. · Clinical Rheumatology · 2016 · 29 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +16